Cargando…
Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients.
The aim of this study was to investigate the effect of the cyclo-oxygenase inhibitor ibuprofen on the acute-phase protein response and resting energy expenditure (REE) of weight-losing patients with pancreatic cancer. Patients with irresectable pancreatic cancer (n = 16) were treated with either ibu...
Autores principales: | Wigmore, S. J., Falconer, J. S., Plester, C. E., Ross, J. A., Maingay, J. P., Carter, D. C., Fearon, K. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034153/ https://www.ncbi.nlm.nih.gov/pubmed/7541236 |
Ejemplares similares
-
Changes in nutritional status associated with unresectable pancreatic cancer.
por: Wigmore, S. J., et al.
Publicado: (1997) -
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss
por: McMillan, D C, et al.
Publicado: (1999) -
Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines.
por: Falconer, J. S., et al.
Publicado: (1994) -
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids
por: Moses, A W G, et al.
Publicado: (2004) -
From the past to future: from energy expenditure to energy intake to energy expenditure
por: Müller, M J, et al.
Publicado: (2017)